Cargando…
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690912/ https://www.ncbi.nlm.nih.gov/pubmed/37259597 http://dx.doi.org/10.3324/haematol.2022.282345 |
_version_ | 1785152623487221760 |
---|---|
author | Crombie, Jennifer L. Jacobson, Caron A. Redd, Robert Shouse, Geoffrey Herrera, Alex F. Chow, Victor A. Gauthier, Jordan Mullane, Erin Cahill, Kirk Kline, Justin Romancik, Jason Cohen, Jonathon B. Saucier, Anna Houot, Roch Armand, Philippe Hess, Brian |
author_facet | Crombie, Jennifer L. Jacobson, Caron A. Redd, Robert Shouse, Geoffrey Herrera, Alex F. Chow, Victor A. Gauthier, Jordan Mullane, Erin Cahill, Kirk Kline, Justin Romancik, Jason Cohen, Jonathon B. Saucier, Anna Houot, Roch Armand, Philippe Hess, Brian |
author_sort | Crombie, Jennifer L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10690912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-106909122023-12-02 Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy Crombie, Jennifer L. Jacobson, Caron A. Redd, Robert Shouse, Geoffrey Herrera, Alex F. Chow, Victor A. Gauthier, Jordan Mullane, Erin Cahill, Kirk Kline, Justin Romancik, Jason Cohen, Jonathon B. Saucier, Anna Houot, Roch Armand, Philippe Hess, Brian Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-06-01 /pmc/articles/PMC10690912/ /pubmed/37259597 http://dx.doi.org/10.3324/haematol.2022.282345 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Crombie, Jennifer L. Jacobson, Caron A. Redd, Robert Shouse, Geoffrey Herrera, Alex F. Chow, Victor A. Gauthier, Jordan Mullane, Erin Cahill, Kirk Kline, Justin Romancik, Jason Cohen, Jonathon B. Saucier, Anna Houot, Roch Armand, Philippe Hess, Brian Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title | Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title_full | Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title_fullStr | Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title_full_unstemmed | Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title_short | Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy |
title_sort | prognostic value of early positron emission tomography in patients with large b-cell lymphoma treated with anti-cd19 chimeric antigen receptor t-cell therapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690912/ https://www.ncbi.nlm.nih.gov/pubmed/37259597 http://dx.doi.org/10.3324/haematol.2022.282345 |
work_keys_str_mv | AT crombiejenniferl prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT jacobsoncarona prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT reddrobert prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT shousegeoffrey prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT herreraalexf prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT chowvictora prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT gauthierjordan prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT mullaneerin prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT cahillkirk prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT klinejustin prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT romancikjason prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT cohenjonathonb prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT saucieranna prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT houotroch prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT armandphilippe prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy AT hessbrian prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy |